The efficacy of LigaSure™ open instruments in cases of cesarean hysterectomy due to placenta percreta: a retrospective, record-based, comparative study

Abstract Objective The standard treatment for patients with placenta percreta is cesarean hysterectomy that can cause severe bleeding. New-generation vessel sealing systems like LigaSure can cut and seal vascular structures and tissues. The aim of this study was to retrospectively compare hysterectomies performed with traditional instruments and those performed with LigaSure instruments to determine the possible advantages with the latter. Materials and Methods Patients with placenta percreta who underwent elective cesarean hysterectomy by the same surgeon were divided into two groups based on the type of instruments used. Group 1, the standard conventional hysterectomy group, operated with conventional instruments for cutting and tying; and Group 2, the LigaSure hysterectomy group, operated with the new-generation bipolar sealing and cutting instruments. The groups were retrospectively compared for bleeding, operating time, and complications. Results In Group 2, the operating time, intraoperative and total transfused erythrocyte suspension units, total fluid in the drain, and total hospital stay were lower than in Group 1 (p < .05), as was the need for internal iliac artery ligation (p = .013). The complication rates were similar between the two groups (p > .05). Conclusion The use of LigaSure open instruments in cesarean hysterectomies in patients with placenta percreta may reduce operating times and the amount of bleeding.

[1]  P. Guerby,et al.  Perioperative outcomes using LigaSure compared with conventional technique in peripartum hysterectomy , 2019, Archives of Gynecology and Obstetrics.

[2]  K. Goetzinger,et al.  A novel approach to reduce blood loss in patients with placenta accreta spectrum disorder , 2019, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[3]  J. Langhoff‐Roos,et al.  FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders , , 2019, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[4]  F. D’Antonio,et al.  Updates on the management of placenta accreta spectrum. , 2019, Minerva ginecologica.

[5]  Meng Chen,et al.  Internal iliac artery balloon occlusion during cesarean hysterectomy in women with placenta previa accreta , 2019, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[6]  Gynecologists Obstetric Care Consensus No. 7: Placenta Accreta Spectrum. , 2018, Obstetrics and gynecology.

[7]  P. Saha,et al.  An alternate surgical approach to reduce hemorrhage and complications during cesarean hysterectomy for adherent placenta. , 2018, European journal of obstetrics, gynecology, and reproductive biology.

[8]  P. Dursun Use of bulldog vascular clamps to reduce intraoperative bleeding during cesarean hysterectomy for placenta percreta , 2018, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[9]  E. Jauniaux,et al.  FIGO consensus guidelines on placenta accreta spectrum disorders: Nonconservative surgical management , , 2018, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[10]  K. Baba,et al.  Study of the utility and problems of common iliac artery balloon occlusion for placenta previa with accreta , 2018, The journal of obstetrics and gynaecology research.

[11]  D. Jurkovic,et al.  Accreta placentation: a systematic review of prenatal ultrasound imaging and grading of villous invasiveness. , 2016, American journal of obstetrics and gynecology.

[12]  A. Kucuk,et al.  Surgical management of 58 patients with placenta praevia percreta , 2016, Wiener klinische Wochenschrift.

[13]  G. Buonocore,et al.  Neonatomics and childomics: the right route to the future , 2014, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[14]  R. Silver,et al.  Placenta accreta and maternal morbidity in the Republic of Ireland, 2005–2010 , 2014, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[15]  C. Saccardi,et al.  LigaSure vessel sealing system in vaginal hysterectomy: safety, efficacy and limitations , 2013, Archives of Gynecology and Obstetrics.

[16]  Jason D. Wright,et al.  Practice patterns and knowledge of obstetricians and gynecologists regarding placenta accreta , 2013, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[17]  R. Silver,et al.  Maternal Morbidity in Cases of Placenta Accreta Managed by a Multidisciplinary Care Team Compared With Standard Obstetric Care , 2011, Obstetrics and gynecology.

[18]  F. Fama’,et al.  LigaSure vs clamp-and-tie technique to achieve hemostasis in total thyroidectomy for benign multinodular goiter: a prospective randomized study. , 2007, Archives of surgery.

[19]  M. Belfort,et al.  Minimizing blood loss at cesarean-hysterectomy for placenta previa percreta. , 2017, American journal of obstetrics and gynecology.